Human peripheral blood Valpha24+ Vbeta11+ NKT cells expand following administration of alpha-galactosylceramide-pulsed dendritic cells

We have undertaken the first clinical trial involving the administration of alpha-GalactosylCeramine (alpha-GalCer)-pulsed dendritic cells (DCs) to human subjects, to determine safety, optimal dose, optimal administration route and immunological effects. Subjects (n = 4) with metastatic malignancy r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Vox sanguinis 2002-10, Vol.83 (3), p.250-253
Hauptverfasser:	Okai, M, Nieda, M, Tazbirkova, A, Horley, D, Kikuchi, A, Durrant, S, Takahashi, T, Boyd, A, Abraham, R, Yagita, H, Juji, T, Nicol, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Cells Cell Division Dendritic Cells - immunology Dendritic Cells - transplantation Flow Cytometry Galactosylceramides - immunology Humans Immunotherapy, Adoptive - methods Killer Cells, Natural - cytology Killer Cells, Natural - immunology Lymphocyte Count Neoplasms - therapy T-Lymphocytes - cytology T-Lymphocytes - immunology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!